In accordance with this, we found that IGFBP5 serves as a cancer promoter based on our findings in the clinical CRC cohort and CRC cell lines (Figs. 3 and 4 and Table 2 ). The gene discussed is IGFBP5; the disease is colorectal carcinoma.